Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Por um escritor misterioso
Descrição
COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun
Ritedose Sodium Chloride for Inhalation 7% is a sterile, aqueous solution of sodium chloride for inhalation. The solution is used to help loosen and
Ritedose Sodium Chloride for Inhalation 7% Unit Dose 4 mL Ampule Vials
Ritedose Pharmaceuticals 76204090001 - McKesson Medical-Surgical
Cardinal 8881570300 - McKesson Medical-Surgical
Novo Holdings buys sterile injectables maker Ritedose for
The Ritedose Corporation
Labetalol LABETALOL, Labetalol HCL Inj; Vial; 5mg/mL. 20 mL $28.75
Pfizer 00409488820 - McKesson Medical-Surgical
Pfizer 00409226720 - McKesson Medical-Surgical
News – The Ritedose Corporation
Ritedose Sodium Chloride for Inhalation 7% Unit Dose 4 mL Ampule
Ritedose Pharmaceuticals 76204090001 - McKesson Medical-Surgical
Almaject Inc 47781058629 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol
Labetalol HCI Injection Vial, USP 20 mg/4 mL (5 mg/mL
2021 – The Ritedose Corporation
de
por adulto (o preço varia de acordo com o tamanho do grupo)